BioArctic moves to Nasdaq Stockholm Large Cap
Stockholm, January 2, 2023 – As of today, BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) will move to the Large Cap listing on the Nasdaq Stockholm stock exchange."The move to the Large Cap on Nasdaq Stockholm is an important milestone in BioArctic’s development," said Gunilla Osswald, CEO at BioArctic. "We will enter 2023 with the momentum of this honor, and look forward to another year with several key milestones for our company and for our community of patients and stakeholders." BioArctic’s current market capital is close to of SEK 24 billion and the share has risen over 128% during